Exercise Tolerance and Lower-limb Muscle Power in Patients With Chronic Respiratory Disease
NCT ID: NCT06124859
Last Updated: 2023-11-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
30 participants
INTERVENTIONAL
2023-11-30
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
As the reproducibility of the tests has been studied and validated in previous studies, the objective is to investigate the validity of the 6MST and 5STS in comparison with their respective gold standards.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Six-minute Stepper Test as an Outcome Measure of Exercise Tolerance During Pulmonary Rehabilitation in With Chronic Obstructive Pulmonary Disease (COPD) Patients(STEPPER)?
NCT01759199
Assessing Functional Capacity in Directly and Remotely Monitored Home-based Settings: A Protocol for a Multinational Validation Study in Individuals With Chronic Respiratory Diseases
NCT06447831
Effects of Knee-extensor Exercise Training in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01079221
Effect and Feasibility of Non-linear Periodized Resistance Training in People With COPD
NCT03518723
Respiratory Rehabilitation for Patients With Chronic Obstructive Pulmonary Disease
NCT03453606
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with a diagnosis of COPD (GOLD II- V) or pulmonary fibrosis (>6 months).
Functional capacity tests
Maximal effort test on cycloergometer (1st visit)
Maximal effort test, 6-minute stepper test, 6-minute walk test, 5-times sit to stand test. A minimum rest period of 15 minutes must be observed between these tests (2nd Visit)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Functional capacity tests
Maximal effort test on cycloergometer (1st visit)
Maximal effort test, 6-minute stepper test, 6-minute walk test, 5-times sit to stand test. A minimum rest period of 15 minutes must be observed between these tests (2nd Visit)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With a diagnosis of chronic obstructive pulmonary disease (GOLD II - IV) or pulmonary fibrosis (\>6 months).
* Able to understand and follow verbal instructions during tests
* Affiliated with a social security scheme
* Willing to participate in the study
Exclusion Criteria
* Having undergone respiratory rehabilitation within the last year.
* With unstable disease (recent exacerbation \< 4 weeks).
* Pregnant and/or breast-feeding women
* Patients under guardianship or curatorship
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Lille Nord de France
OTHER
Lille Catholic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arnaud CHAMBELLAN, MD
Role: PRINCIPAL_INVESTIGATOR
Hôpital Saint Philibert, GHICL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre de Pneumologie Institut universitaire de cardiologie et de pneumologie de Québec
Québec, , Canada
Hôpital Saint-Philibert (GHICL)
Lomme, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC-P00120
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.